SignatureFD’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$622K Buy
1,906
+151
+9% +$49.2K 0.01% 490
2025
Q1
$474K Buy
1,755
+115
+7% +$31.1K 0.01% 547
2024
Q4
$386K Sell
1,640
-214
-12% -$50.4K 0.01% 609
2024
Q3
$510K Buy
1,854
+471
+34% +$130K 0.01% 519
2024
Q2
$336K Buy
1,383
+284
+26% +$69K 0.01% 625
2024
Q1
$164K Sell
1,099
-90
-8% -$13.5K ﹤0.01% 916
2023
Q4
$228K Buy
1,189
+14
+1% +$2.68K 0.01% 743
2023
Q3
$208K Sell
1,175
-493
-30% -$87.3K 0.01% 733
2023
Q2
$317K Buy
1,668
+223
+15% +$42.4K 0.01% 596
2023
Q1
$289K Sell
1,445
-159
-10% -$31.9K 0.01% 604
2022
Q4
$381K Buy
1,604
+59
+4% +$14K 0.01% 498
2022
Q3
$309K Buy
1,545
+1,057
+217% +$211K 0.01% 526
2022
Q2
$71K Sell
488
-510
-51% -$74.2K ﹤0.01% 1126
2022
Q1
$163K Buy
998
+75
+8% +$12.2K ﹤0.01% 809
2021
Q4
$157K Sell
923
-29
-3% -$4.93K ﹤0.01% 816
2021
Q3
$180K Buy
952
+12
+1% +$2.27K 0.01% 732
2021
Q2
$159K Buy
940
+136
+17% +$23K 0.01% 756
2021
Q1
$114K Sell
804
-149
-16% -$21.1K 0.01% 810
2020
Q4
$124K Buy
953
+473
+99% +$61.5K 0.01% 691
2020
Q3
$70K Buy
480
+245
+104% +$35.7K ﹤0.01% 836
2020
Q2
$35K Buy
235
+45
+24% +$6.7K ﹤0.01% 1091
2020
Q1
$21K Buy
190
+141
+288% +$15.6K ﹤0.01% 1203
2019
Q4
$6K Buy
49
+17
+53% +$2.08K ﹤0.01% 1585
2019
Q3
$3K Hold
32
﹤0.01% 1693
2019
Q2
$2K Buy
+32
New +$2K ﹤0.01% 1734
2018
Q4
Sell
-61
Closed -$5K 1925
2018
Q3
$5K Hold
61
﹤0.01% 1526
2018
Q2
$6K Buy
61
+35
+135% +$3.44K ﹤0.01% 1499
2018
Q1
$3K Buy
+26
New +$3K ﹤0.01% 1473
2016
Q2
Sell
-37
Closed -$2K 1412
2016
Q1
$2K Buy
+37
New +$2K ﹤0.01% 1136
2015
Q4
Sell
-20
Closed -$2K 1279
2015
Q3
$2K Buy
+20
New +$2K ﹤0.01% 995